C R Prentice. Show Affiliations »
Abstract
Mesh： See more » Aminocaproates/adverse effectsAminocaproates/therapeutic useAntifibrinolytic Agents/therapeutic useAprotinin/therapeutic useBlood Coagulation Disorders/drug therapyDisseminated Intravascular Coagulation/drug therapyFemaleGastrointestinal Hemorrhage/drug therapyHematuria/drug therapyHemophilia A/complicationsHemophilia A/drug therapyHemophilia B/drug therapyHemorrhage/drug therapyHumansKidney Diseases/chemically inducedMaleMenorrhagia/drug therapyPostoperative Complications/drug therapySubarachnoid Hemorrhage/drug therapyThromboembolism/chemically inducedTranexamic Acid/therapeutic use
Substances： See more » AminocaproatesAntifibrinolytic AgentsTranexamic AcidAprotinin
Year: 1975 PMID： 1108280
Source DB: PubMed Journal: Thromb Diath Haemorrh ISSN： 0340-5338